Rocket Pharmaceuticals, Inc.Rocket Pharmaceuticals, Inc.Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪2.14 B‬USD
−2.94USD
‪−245.60 M‬USD
‪84.00 M‬
Beta (1Y)
1.77

About Rocket Pharmaceuticals, Inc.

CEO
Gaurav D. Shah
Headquarters
Cranbury
Employees (FY)
268
Founded
1999
ISIN
US77313F1066
FIGI
BBG000WG3567
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of RCKT is 23.42 USD — it has decreased by 0.26% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Rocket Pharmaceuticals, Inc. stocks are traded under the ticker RCKT.
Rocket Pharmaceuticals, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
RCKT stock is 1.59% volatile and has beta coefficient of 1.77. Check out the list of the most volatile stocks — is Rocket Pharmaceuticals, Inc. there?
One year price forecast for Rocket Pharmaceuticals, Inc. has a max estimate of 65.00 USD and a min estimate of 39.00 USD.
RCKT earnings for the last quarter are −0.75 USD per share, whereas the estimation was −0.81 USD resulting in a 7.88% surprise. The estimated earnings for the next quarter are −0.78 USD per share. See more details about Rocket Pharmaceuticals, Inc. earnings.
Rocket Pharmaceuticals, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach ‪111.11 K‬ USD.
Yes, you can track Rocket Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
RCKT stock has fallen by 6.88% compared to the previous week, the month change is a 12.74% fall, over the last year Rocket Pharmaceuticals, Inc. has showed a 23.20% increase.
RCKT net income for the last quarter is ‪−59.66 M‬ USD, while the quarter before that showed ‪−61.90 M‬ USD of net income which accounts for 3.62% change. Track more Rocket Pharmaceuticals, Inc. financial stats to get the full picture.
Today Rocket Pharmaceuticals, Inc. has the market capitalization of ‪2.13 B‬, it has decreased by 5.10% over the last week.
No, RCKT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, RCKT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Rocket Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
RCKT reached its all-time high on Jul 24, 2015 with the price of 77.80 USD, and its all-time low was 3.40 USD and was reached on Jul 10, 2017.
See other stocks reaching their highest and lowest prices.
As of Apr 19, 2024, the company has 268.00 employees. See our rating of the largest employees — is Rocket Pharmaceuticals, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Rocket Pharmaceuticals, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Rocket Pharmaceuticals, Inc. stock shows the buy signal. See more of Rocket Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Rocket Pharmaceuticals, Inc. future price: according to them, RCKT price has a max estimate of 65.00 USD and a min estimate of 39.00 USD. Read a more detailed Rocket Pharmaceuticals, Inc. forecast: see what analysts think of Rocket Pharmaceuticals, Inc. and suggest that you do with its stocks.